The observation that dysregulated IL-1β signaling occurs disproportionately in persons with MDR-TB has been reported previously [28], and inhaled IFN-α, which suppresses IL-1β production in pulmonary TB disease [34] has been studied as a potential treatment for refractory MDR-TB [35]. The gene discussed is IL1B; the disease is multidrug-resistant tuberculosis.